CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
3.020
+0.080 (2.72%)
At close: Mar 9, 2026, 4:00 PM EDT
3.040
+0.020 (0.66%)
After-hours: Mar 9, 2026, 5:49 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $1.87 million as of March 9, 2026. Its market cap has decreased by -66.68% in one year.
Market Cap
1.87M
Enterprise Value
-7.97M
1-Year Change
-66.68%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $1.87M, a decrease of -97.32%. That is a compound annual growth rate of -43.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 2.64M |
| 60 Degrees Pharmaceuticals | 2.64M |
| Artelo Biosciences | 2.42M |
| PMGC Holdings | 2.40M |
| Bone Biologics | 2.30M |
| Lyra Therapeutics | 2.27M |
| Clearmind Medicine | 2.05M |
| Adial Pharmaceuticals | 2.03M |